Differences in Ovarian Aging Between Caucasian and Indian Women
NCT ID: NCT02210013
Last Updated: 2014-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2012-01-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women
NCT03998553
Telomeres and Reproduction in Women
NCT01576991
Clinical Measures of Ovarian Reserve in Predicting IVF Success
NCT01756872
Influence of Ethnical Differences on the Egg Cell Collected in Patients Undergoing Fertility Treatment
NCT03927417
Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women
NCT06103383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The date we will collect in both groups include the age, the body mass index, and the ovarian reserve markers like the antral follicle count (AFC), the follicle stimulation hormone (FSH) and antimullerian hormone (AMH) serum levels.
The investigators will also determine the number of oocytes retrieved and the metaphase two oocytes in both groups after IVF stimulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Caucasian women
200 Caucasian infertile women undergoing their first or second IVF cycle
No interventions assigned to this group
Indian women
200 Indian women undergoing their first or second IVF cycle.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IVI Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juan A Garcia-Velasco
Juan A Garcia-Velasco, MD, Phd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Iglesias, M.D.
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Manish Banker, M.D.
Role: PRINCIPAL_INVESTIGATOR
NOVA IVI
Nalini Mahajan, M.D.
Role: PRINCIPAL_INVESTIGATOR
NOVA IVI
Leyre Herrero, Ph. D.
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Antonio Pellicer, M.D.
Role: PRINCIPAL_INVESTIGATOR
IVI VALENCIA
Juan Antonio Garcia-Velasco, M.D.
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAD-CI-01-2012-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.